Native SEC and Reversed-Phase LC–MS Reveal Impact of Fab Glycosylation of Anti-SARS-COV-2 Antibodies on Binding to the Receptor Binding Domain
Analytical Chemistry · 2023
DOI: 10.1021/acs.analchem.2c05554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2023. Verfasst von Daniel W Woodall und 6 weiteren Autor:innen. Beteiligte Einrichtung: Attribute Sciences, Process Development, Amgen Inc., Thousand Oaks, California 91320, United States. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Attribute Sciences, Process Development, Amgen Inc., Thousand Oaks, California 91320, United States.
- Discovery Protein Science, Amgen Research, Amgen Inc., Burnaby, BC V5A1 V7, Canada.
- Drug Product Technologies, Process Development, Amgen Inc., Thousand Oaks, California 91320, United States.
- Biologics Discovery, Amgen Research, Amgen Inc., Burnaby, BC V5A1 V7, Canada.
ORCID-Profile: Pavel V Bondarenko
Zitieren
APA
Woodall, D. W., Thomson, C. A., Dillon, T. M., McAuley, A., Green, L. B., Foltz, I. N., & Bondarenko, P. V. (2023). Native SEC and Reversed-Phase LC–MS Reveal Impact of Fab Glycosylation of Anti-SARS-COV-2 Antibodies on Binding to the Receptor Binding Domain. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.2c05554
Vancouver
Woodall DW, Thomson CA, Dillon TM, McAuley A, Green LB, Foltz IN, et al. Native SEC and Reversed-Phase LC–MS Reveal Impact of Fab Glycosylation of Anti-SARS-COV-2 Antibodies on Binding to the Receptor Binding Domain. Analytical Chemistry. 2023. doi:10.1021/acs.analchem.2c05554
BibTeX
@article{Woodall2023,
author = {Woodall, Daniel W and Thomson, Christy A and Dillon, Thomas M and McAuley, Arnold and Green, Lydia B and Foltz, Ian N and Bondarenko, Pavel V},
title = {Native SEC and Reversed-Phase LC–MS Reveal Impact of Fab Glycosylation of Anti-SARS-COV-2 Antibodies on Binding to the Receptor Binding Domain},
journal = {Analytical Chemistry},
year = {2023},
doi = {10.1021/acs.analchem.2c05554}
}
EUVIMED